Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 139
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Brampton, Etobicoke, Toronto (Basal insulin glargine and lixisenatide, Basal insulin Basaglar/Lantus +

Completed
  • Diabetes Mellitus, Type 2
  • Basal insulin glargine and lixisenatide
  • +2 more
  • Brampton, Ontario, Canada
  • +2 more
Feb 24, 2021

Coronary Arteriosclerosis, Diabetes, Type 2, Cerebrovascular Accident Trial in Worldwide (Atorvastatin (Lipitor))

Completed
  • Coronary Arteriosclerosis
  • +4 more
  • Atorvastatin (Lipitor)
  • Mississauga, Ontario, Cameroon
  • +120 more
Feb 17, 2021

NAFLD, Diabetes, Type 2, Hypertriglyceridemia Trial in Canada, United States (Placebo, ISIS 703802 40 mg, ISIS 703802 80 mg)

Completed
Has Results
  • NAFLD
  • +3 more
  • Placebo
  • +3 more
  • Chandler, Arizona
  • +41 more
Jan 28, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +102 more
Jan 14, 2021

Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Chandler, Arizona
  • +66 more
Dec 16, 2020

Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Pell City, Alabama
  • +175 more
Dec 11, 2020

Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Searcy, Arkansas
  • +157 more
Nov 13, 2020

Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • MEDI0382 low dose
  • +4 more
  • Birmingham, Alabama
  • +118 more
Jul 31, 2020

Diabetes, Type 1, Diabetes, Type 2, Obesity Trial in Toronto (Empagliflozin, Placebo (matching empagliflozin), ramipril)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • +2 more
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 23, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Diabetes, Type 2 Trial in Worldwide (Dulaglutide)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Chandler, Arizona
  • +207 more
May 28, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +118 more
Feb 14, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +118 more
Jan 8, 2020

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Tresiba® After Switching Basal Insulin inPopulation With Type 1

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Calgary, Alberta, Canada
  • +31 more
Dec 5, 2019

Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathy
  • Birmingham, Alabama
  • +592 more
Dec 4, 2019

Prediction of Neuropathy in Type 1 Diabetes

Completed
  • Diabetic Polyneuropathy
  • +4 more
  • Exposure: Corneal nerve fibre morphology by the CCM Procedure
  • Ann Arbor, Michigan
  • +4 more
Nov 4, 2019

Viscous Fiber on Glycemic Control in Individuals With Diabetes

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Viscous Fiber
  • Toronto, Ontario, Canada
    Clinical Nutrition and Risk Factor Modification Centre
Oct 28, 2019

Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +300 more
Sep 18, 2019

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +85 more
May 28, 2019

Diabetes, Type 2, Diabetes, Type 1 Trial in Toronto (a mail letter, a phone call and a phone call plus mailed letter)

Unknown status
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1
  • a mail letter, a phone call and a phone call plus mailed letter
  • Toronto, Ontario, Canada
  • +1 more
Apr 23, 2019